![]() Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 2011 | Founding Date 2018 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Stamford, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 5 | Employees 2263% decrease |

Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company